NCT06085326 Smart Checklist Implementation for Pediatric Tracheal Intubations in the ICU- Multicenter Study
| NCT ID | NCT06085326 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's Hospital of Philadelphia |
| Condition | Intubation Complication |
| Study Type | INTERVENTIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2023-10-01 |
| Primary Completion | 2028-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 3,000 participants in total. It began in 2023-10-01 with a primary completion date of 2028-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the study is to implement a patient-provider dyad tailored, Electronic Health Record (EHR)-informed, digitized Smart Checklist as a Quality Improvement (QI) intervention to support bedside clinician teams to reduce Adverse Airway Outcomes (AAO) across 6 diverse pediatric intensive care units (ICUs).
Eligibility Criteria
Inclusion Criteria: All patients intubated in the PICU at participating sites Exclusion Criteria: Endotracheal tube exchanges, as this represents a distinct procedure
Contact & Investigator
Akira Nishisaki, MD, MSCE
PRINCIPAL INVESTIGATOR
Children's Hospital of Philadelphia
Frequently Asked Questions
Who can join the NCT06085326 clinical trial?
This trial is open to participants of all sexes, up to 19 Years, studying Intubation Complication. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06085326 currently recruiting?
Yes, NCT06085326 is actively recruiting participants. Contact the research team at nishisaki@chop.edu for enrollment information.
Where is the NCT06085326 trial being conducted?
This trial is being conducted at Little Rock, United States, Atlanta, United States, Omaha, United States, Akron, United States and 2 additional locations.
Who is sponsoring the NCT06085326 clinical trial?
NCT06085326 is sponsored by Children's Hospital of Philadelphia. The principal investigator is Akira Nishisaki, MD, MSCE at Children's Hospital of Philadelphia. The trial plans to enroll 3,000 participants.